-
Amarnath S, Dong L, Li J, Wu Y, Chen W, 2007: Endogenous TGF-β activation by reactive oxygen species is key to Foxp3 induction in TCR-stimulated and HIV-1-infected human CD4+CD25- T cells[J]. Retrovirology, 4, 57-. doi: 10.1186/1742-4690-4-57
-
Angerami MT, Suarez GV, Vecchione MB, Laufer N, Ameri D, Ben G, Perez H, Sued O, Salomón H, Quiroga MF, 2017: Expansion of CD25-negative forkhead box P3-positive T cells during HIV and mycobacterium tuberculosis infection[J]. Front Immunol, 8, 528-. doi: 10.3389/fimmu.2017.00528
-
Beyer M, Thabet Y, Müller RU, Sadlon T, Classen S, Lahl K, Basu S, Zhou X, Bailey-Bucktrout SL, Krebs W, 2011: Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation[J]. Nat Immunol, 12, 898-907. doi: 10.1038/ni.2084
-
Brenchley JM, Douek DC, 2008: HIV infection and the gastrointestinal immune system[J]. Mucosal Immunol, 1, 23-30. doi: 10.1038/mi.2007.1
-
Catalfamo M, Le Saout C, Lane HC, 2012: The role of cytokines in the pathogenesis and treatment of HIV infection[J]. Cytokine Growth Factor Rev, 23, 207-214. doi: 10.1016/j.cytogfr.2012.05.007
-
Chevalier MF, Petitjean G, Dunyach-Rémy C, Didier C, Girard PM, Manea ME, Campa P, Meyer L, Rouzioux C, Lavigne JP, Barré-Sinoussi F, Scott-Algara D, Weiss L, 2013: The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation[J]. PLoS Pathog, 9, e1003453-. doi: 10.1371/journal.ppat.1003453
-
Chevalier MF, Weiss L, 2013: The split personality of regulatory T cells in HIV infection[J]. Blood, 121, 29-37. doi: 10.1182/blood-2012-07-409755
-
Dominick L, Midgley N, Swart LM, Sprake D, Deshpande G, Laher I, Joseph D, Teer E, Essop MF, 2020: HIV-related cardiovascular diseases: the search for a unifying hypothesis[J]. Am J Physiol - Hear Circ Physiol, 318, H731-H746. doi: 10.1152/ajpheart.00549.2019
-
Elkord E, Abd Al Samid M, Chaudhary B, 2015: Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP[J]. Oncotarget, 6, 20026-20036. doi: 10.18632/oncotarget.4771
-
Fan MY, Low JS, Tanimine N, Finn KK, Priyadharshini B, Germana SK, Kaech SM, Turka LA, 2018: Differential roles of IL-2 signaling in developing versus mature tregs[J]. Cell Rep, 25, 1204-1213. doi: 10.1016/j.celrep.2018.10.002
-
Février M, Dorgham K, Rebollo A, 2011: CD4+ T cell depletion in human immunodeficiency virus (HIV) infection: role of apoptosis[J]. Viruses, 3, 586-612. doi: 10.3390/v3050586
-
Floess S, Freyer J, Siewert C, Baron U, Olek S, Polansky J, Schlawe K, Chang HD, Bopp T, Schmitt E, Klein-Hessling S, Serfling E, Hamann A, Huehn J, 2007: Epigenetic control of the foxp3 locus in regulatory T cells[J]. PLoS Biol, 5, e38-. doi: 10.1371/journal.pbio.0050038
-
Fontenot JD, Gavin MA, Rudensky AY, 2003: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells[J]. Nat Immunol, 4, 330-336. doi: 10.1038/ni904
-
Furtado GC, De Curotto Lafaille MA, Kutchukhidze N, Lafaille JJ, 2002: Interleukin 2 signaling is required for CD4+ regulatory T cell function[J]. J Exp Med, 196, 851-857. doi: 10.1084/jem.20020190
-
Grzanka J, Leveson-Gower D, Golab K, Wang XJ, Marek-Trzonkowska N, Krzystyniak A, Wardowska A, Mills JM, Trzonkowski P, Witkowski P, 2013: FoxP3, Helios, and SATB1: roles and relationships in regulatory T cells[J]. Int Immunopharmacol, 16, 343-347. doi: 10.1016/j.intimp.2013.02.004
-
Horwitz DA, 2010: Identity of mysterious CD4+CD25-Foxp3+ cells in SLE[J]. Arthritis Res Ther, 12, 101-. doi: 10.1186/ar2894
-
Keynan Y, Card CM, McLaren PJ, Dawood MR, Kasper K, Fowke KR, 2008: The role of regulatory T cells in chronic and acute viral infections[J]. Clin Infect Dis, 46, 1046-1052. doi: 10.1086/529379
-
Kleinman AJ, Sivanandham R, Pandrea I, Chougnet CA, Apetrei C, 2018: Regulatory T cells as potential targets for HIV cure research[J]. Front Immunol, 9, 734-. doi: 10.3389/fimmu.2018.00734
-
Kondo M, Tanaka Y, Kuwabara T, Naito T, Kohwi-Shigematsu T, Watanabe A, 2016: SATB1 plays a critical role in establishment of immune tolerance[J]. J Immunol, 196, 563-572. doi: 10.4049/jimmunol.1501429
-
Kuller, Tracy, Belloso, De Wit, Drummond, Lane, Ledergerber, Lundgren, Neuhaus, Nixon, Paton, Neaton, INSIGHT SMART Study Group, 2008: Inflammatory and coagulation biomarkers and mortality in patients with HIV infection[J]. PLoS Med, 5, e203-. doi: 10.1371/journal.pmed.0050203
-
Metelli A, Salem M, Wallace CH, Wu BX, Li A, Li X, Li Z, 2018: Immunoregulatory functions and the therapeutic implications of GARP-TGF-β in inflammation and cancer[J]. J Hematol Oncol, 11, 24-. doi: 10.1186/s13045-018-0570-z
-
Miller MM, Fogle JE, Ross P, Tompkins MB, 2013: Feline glycoprotein A repetitions predominant anchors transforming growth factor beta on the surface of activated CD4(+)CD25(+) regulatory T cells and mediates AIDS lentivirus-induced T cell immunodeficiency[J]. AIDS Res Hum Retroviruses, 29, 641-651. doi: 10.1089/aid.2012.0322
-
Miller MM, Petty CS, Tompkins MB, Fogle JE, 2014: CD4+CD25+ T regulatory cells activated during feline immunodeficiency virus infection convert T helper cells into functional suppressors through a membrane-bound TGFβ / GARP-mediated mechanism[J]. Virol J, 11, 7-. doi: 10.1186/1743-422X-11-7
-
Min B, 2017: Heterogeneity and Stability in Foxp3+ regulatory T cells[J]. J Interferon Cytokine Res, 37, 386-397. doi: 10.1089/jir.2017.0027
-
Moreno-Fernandez ME, Presicce P, Chougnet CA, 2012: Homeostasis and function of regulatory T cells in HIV/SIV infection[J]. J Virol, 86, 10262-10269. doi: 10.1128/JVI.00993-12
-
Naicker, Werner, Kormuth, Passmore, Mlisana, Karim, Ndung'u, CAPRISA Acute Infection Study Team, 2009: Interleukin-10 promoter polymorphisms influence HIV-1 susceptibility and primary HIV-1 pathogenesis[J]. J Infect Dis, 200, 448-452. doi: 10.1086/600072
-
Nou E, Lo J, Grinspoon SK, 2016: Inflammation, immune activation, and cardiovascular disease in HIV[J]. AIDS, 30, 1495-1509. doi: 10.1097/QAD.0000000000001109
-
Paiardini M, Müller-Trutwin M, 2013: HIV-associated chronic immune activation[J]. Immunol Rev, 254, 78-101. doi: 10.1111/imr.12079
-
Prabhakar B, Banu A, Pavithra HB, Chandrashekhara P, Sasthri S, 2011: Immunological failure despite virological suppression in HIV seropositive individuals on antiretroviral therapy[J]. Indian J Sex Transm Dis AIDS, 32, 94-98. doi: 10.4103/0253-7184.85412
-
Probst-Kepper M, Buer J, 2010: FOXP3 and GARP (LRRC32): the master and its minion[J]. Biol Direct, 5, 8-. doi: 10.1186/1745-6150-5-8
-
Rajasuriar R, Khoury G, Kamarulzaman A, French MA, Cameron PU, Lewin SR, 2013: Persistent immune activation in chronic HIV infection: do any interventions work?[J]. AIDS, 27, 1199-1208. doi: 10.1097/QAD.0b013e32835ecb8b
-
Rojas JM, Avia M, Martín V, Sevilla N, 2017: IL-10: a multifunctional cytokine in viral infections[J]. J Immunol Res, 2017, 1-14. doi: 10.1155/2017/6104054
-
Stockis J, Colau D, Coulie PG, Lucas S, 2009: Membrane protein GARP is a receptor for latent TGF-beta on the surface of activated human Treg[J]. Eur J Immunol, 39, 3315-3322. doi: 10.1002/eji.200939684
-
Stylianou E, Aukrust P, Kvale D, Müller F, Frøland SS, 1999: IL-10 in HIV infection: increasing serum IL-10 levels with disease progression-down-regulatory effect of potent anti-retroviral therapy[J]. Clin Exp Immunol, 116, 115-120. doi: 10.1046/j.1365-2249.1999.00865.x
-
Suchard MS, Mayne E, Green VA, Shalekoff S, Donninger SL, Stevens WS, Gray CM, Tiemessen CT, 2010: FOXP3 expression is upregulated in CD4+T cells in progressive HIV-1 infection and is a marker of disease severity[J]. PLoS ONE, 5, e11762-. doi: 10.1371/journal.pone.0011762
-
Teer E, Joseph DE, Driescher N, Nell TA, Dominick L, Midgley N, Deshpande G, Page MJ, Pretorius E, Woudberg NJ, Lecour S, Glashoff RH, Essop MF, 2019: HIV and cardiovascular diseases risk: exploring the interplay between T-cell activation, coagulation, monocyte subsets, and lipid subclass alterations[J]. Am J Physiol - Heart Circ Physiol, 316, H1146-H1157. doi: 10.1152/ajpheart.00797.2018
-
Valverde-Villegas JM, Matte MCC, De MRM, Chies JAB, 2015: New Insights about Treg and Th17 Cells in HIV infection and disease progression[J]. J Immunol Res, 2015, 1-14.
-
Walker MR, Kasprowicz DJ, Gersuk VH, Benard A, Van Landeghen M, Buckner JH, Ziegler SF, 2003: Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells[J]. J Clin Invest, 112, 1437-1443. doi: 10.1172/JCI19441
-
Wan YY, Flavell RA, 2007: 'Yin-Yang' functions of transforming growth factor-β and T regulatory cells in immune regulation[J]. Immunol Rev, 220, 199-213. doi: 10.1111/j.1600-065X.2007.00565.x
-
Wang R, Kozhaya L, Mercer F, Khaitan A, Fujii H, Unutmaz D, 2009: Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells[J]. Proc Natl Acad Sci, 106, 13439-13444. doi: 10.1073/pnas.0901965106
-
Zelenay S, Lopes-Carvalho T, Caramalho I, Moraes-Fontes MF, Rebelo M, Demengeot J, 2005: Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion[J]. Proc Natl Acad Sci U S A, 102, 4091-4096. doi: 10.1073/pnas.0408679102
-
Zhang B, Zhang X, Tang FL, Zhu LP, Liu Y, Lipsky PE, 2008: Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus[J]. Ann Rheum Dis, 67, 1037-1040. doi: 10.1136/ard.2007.083543